Flynn James E 13D and 13G filings for Nuo Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 09:01 am Sale |
2024-09-30 | 13G | Nuo Therapeutics, Inc. AURX |
Flynn James E | 1,026,324 2.200% |
-1,156,840 (-52.99%) |
Filing |
| 2024-02-12 5:33 pm Sale |
2023-12-31 | 13G | Nuo Therapeutics, Inc. AURX |
Flynn James E | 2,183,164 5.160% |
-516,836 (-19.14%) |
Filing |
| 2020-10-09 3:29 pm Purchase |
2020-10-05 | 13G | Nuo Therapeutics, Inc. AURX |
Flynn James E | 2,700,000 9.240% |
2,700,000 (New Position) |
Filing |